Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SEATTLE, May 10, 2013 — /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system, today announced its financial results for the first quarter of 2013.
Help employers find you! Check out all the jobs and post your resume.
